Oric Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ORIC on Nasdaq
Location
240 E. Grand Ave., 2 Nd Floor, South San Francisco, CA

Insiders trading volume in the past year

Oric Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pfizer Inc 10%+ Owner $46.2M Dec 23, 2022
Column Group II, Lp 10%+ Owner $30.6M Nov 12, 2021
Jacob Chacko PRESIDENT AND CEO, Director $7.65M -$1.34M -14.9% Dec 15, 2024
Dominic Piscitelli Chief Financial Officer $1.31M -$73.3K -5.31% Dec 15, 2024
Pratik S. Multani Chief Medical Officer $810K -$73.3K -8.29% Dec 15, 2024
Richard Scheller Director $336K May 20, 2021
Lori Anne Kunkel Director $76.9K Jun 12, 2024
Steven L. Hoerter Director Jun 12, 2024
Richard A. Heyman Director Jun 12, 2024
Carl L. Gordon Director, 10%+ Owner Jun 16, 2021
Angie You Director Jun 12, 2024
Mardi Dier Director Jun 12, 2024
Peter Svennilson Director, 10%+ Owner Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for Oric Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.